Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 366,485,700
  • Market Capitalization, $K 366,486
  • Shares Outstanding, K 2,947
  • 60-Month Beta 1.25
  • Price/Earnings ttm 21.07
  • Annual Dividend & Yield 5.55 (4.40%)
  • Most Recent Dividend 5.551 on 12/20/18
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.35 +8.31%
on 05/31/19
126.05 -0.02%
on 06/19/19
+5.98 (+4.98%)
since 05/17/19
3-Month
116.33 +8.33%
on 05/13/19
132.64 -4.99%
on 04/08/19
-4.48 (-3.43%)
since 03/19/19
52-Week
103.25 +22.05%
on 12/24/18
136.84 -7.91%
on 10/01/18
+4.42 (+3.63%)
since 06/19/18

Most Recent Stories

More News
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
BIB : 51.07 (+1.43%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
BIIB : 233.89 (+0.38%)
ALXN : 123.77 (+1.14%)
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
BIB : 51.07 (+1.43%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
BIIB : 233.89 (+0.38%)
ALXN : 123.77 (+1.14%)
Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
BIB : 51.07 (+1.43%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
ALXN : 123.77 (+1.14%)
Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
BIB : 51.07 (+1.43%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
ALXN : 123.77 (+1.14%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

CELG : 97.83 (+0.70%)
VHT : 175.26 (+0.91%)
XLV : 93.27 (+0.90%)
ONCE : 103.22 (+1.25%)
NITE : 25.41 (-0.04%)
BBH : 126.02 (+1.36%)
BMY : 48.61 (+1.72%)
BTEC : 33.87 (+0.27%)
LLY : 115.23 (+0.51%)
FBT : 138.97 (+0.96%)
IYH : 195.74 (+0.91%)
GSK : 41.00 (+1.94%)
XBI : 86.99 (+0.03%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

CELG : 97.83 (+0.70%)
VHT : 175.26 (+0.91%)
XLV : 93.27 (+0.90%)
ONCE : 103.22 (+1.25%)
NITE : 25.41 (-0.04%)
BBH : 126.02 (+1.36%)
BMY : 48.61 (+1.72%)
BTEC : 33.87 (+0.27%)
LLY : 115.23 (+0.51%)
FBT : 138.97 (+0.96%)
IYH : 195.74 (+0.91%)
GSK : 41.00 (+1.94%)
XBI : 86.99 (+0.03%)
Top-Ranked ETF Winners in Dow's Longest Rally in 24 Years

While there are winners in many corners of the space, some ETFs have crushed the Dow Jones by wide margins in three months.

IGN : 54.13 (-0.28%)
XWEB : 91.60 (+0.96%)
PSJ : 96.96 (+1.53%)
QTEC : 83.46 (+0.63%)
PXMG : 59.75 (+0.59%)
XAR : 101.83 (+0.62%)
IGV : 218.22 (+1.52%)
BBH : 126.02 (+1.36%)
FXL : 66.13 (+0.90%)
XSW : 96.61 (+1.01%)
Top-Ranked ETF Winners in Dow's Longest Rally in 24 Years

While there are winners in many corners of the space, some ETFs have crushed the Dow Jones by wide margins in three months.

IGN : 54.13 (-0.28%)
XWEB : 91.60 (+0.96%)
PSJ : 96.96 (+1.53%)
QTEC : 83.46 (+0.63%)
PXMG : 59.75 (+0.59%)
XAR : 101.83 (+0.62%)
IGV : 218.22 (+1.52%)
BBH : 126.02 (+1.36%)
FXL : 66.13 (+0.90%)
XSW : 96.61 (+1.01%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
BIIB : 233.89 (+0.38%)
ALXN : 123.77 (+1.14%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 108.17 (+0.57%)
FBT : 138.97 (+0.96%)
BBH : 126.02 (+1.36%)
GILD : 68.26 (+0.09%)
AMGN : 182.77 (+0.64%)
BIIB : 233.89 (+0.38%)
ALXN : 123.77 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BBH with:

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

2nd Resistance Point 126.68
1st Resistance Point 126.35
Last Price 126.02
1st Support Level 125.39
2nd Support Level 124.76

See More

52-Week High 136.84
Last Price 126.02
Fibonacci 61.8% 124.01
Fibonacci 50% 120.04
Fibonacci 38.2% 116.08
52-Week Low 103.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar